Inflammatory bowel disease, a dysregulated host-microbiota interaction: are probiotics a new therapeutic option?
Howarth
Gordon S
GS
D000818:Animals; D001439:Bacteroides / Q000254:growth & development; D001644:Bifidobacterium / Q000235:genetics / Q000254:growth & development*; D003106:Colon / Q000276:immunology / Q000382:microbiology* / Q000473:pathology; D005243:Feces / Q000382:microbiology; D006801:Humans; D018836:Inflammation Mediators / Q000378:metabolism; D015212:Inflammatory Bowel Diseases / Q000276:immunology / Q000382:microbiology / Q000517:prevention & control*; D007778:Lactobacillus / Q000235:genetics / Q000254:growth & development*; D019936:Probiotics / Q000008:administration & dosage*; D012720:Severity of Illness Index
D018836:Inflammation Mediators